BlackRock Institutional Trust’s Lisata Therapeutics LSTA Stock Holding History

BlackRock Institutional Trust’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$70K	Hold	1,643	–	–	﹤0.01%	3680
2016 Q3	$114K	Hold	1,643	–	–	﹤0.01%	3685
2016 Q2	$145K	Hold	1,643	–	–	﹤0.01%	3665
2016 Q1	$185K	Hold	1,643	–	–	﹤0.01%	3635
2015 Q4	$266K	Sell	1,643 -79	-5%	-$14.5K	﹤0.01%	3603
2015 Q3	$385K	Buy	1,722 +332	+24%	+$83.3K	﹤0.01%	3547
2015 Q2	$390K	Buy	1,390 +44	+3%	+$16.3K	﹤0.01%	3545
2015 Q1	$513K	Sell	1,346 -1	-0.1%	-$542	﹤0.01%	3500
2014 Q4	$762K	Sell	1,347 -37	-3%	-$25.2K	﹤0.01%	3410
2014 Q3	$1.15M	Sell	1,384 -16	-1%	-$14K	﹤0.01%	3280
2014 Q2	$1.37M	Buy	1,400 +1,396	+34,900%	+$1.36M	﹤0.01%	3338
2014 Q1	$4K	Buy	+4	New	+$4.34K	﹤0.01%	3927
2013 Q4	–	Sell	-20	Closed	-$26K	–	3996
2013 Q3	$26K	Buy	+20	New	+$22.2K	﹤0.01%	3869

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

BlackRock Institutional Trust's LSTA Position: Q4 2016 in Review

BlackRock Institutional Trust held its Lisata Therapeutics (LSTA) position steady in Q4 2016 at 1,643 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #3680.

BlackRock Institutional Trust first reported a position in LSTA in Q3 2013 and has held it in 13 quarters since. The position peaked at $1.37M in Q2 2014. 30 funds tracked by Wall St. Rank hold LSTA as of Q4 2016.

BlackRock Institutional Trust held 1,643 shares of Lisata Therapeutics worth $70K as of Q4 2016.
BlackRock Institutional Trust left its Lisata Therapeutics share count unchanged in Q4 2016.
Lisata Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3680 holding.
BlackRock Institutional Trust first reported a position in Lisata Therapeutics in Q3 2013 and has held it in 13 quarters since.
BlackRock Institutional Trust's Lisata Therapeutics position peaked at $1.37M in Q2 2014.
30 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.